Evaluation of bioinformatics databases has shown significantly higher levels of MIF in GBM compared with non-tumor tissues, and MIF expression has been associated with poor prognoses and early recurrence in association with gliomas [7,8]. The gene discussed is MIF; the disease is neoplasm.